Annual Cash & Cash Equivalents
$32.40 M
+$19.81 M+157.34%
December 31, 2023
Summary
- As of February 6, 2025, TRVI annual cash & cash equivalents is $32.40 million, with the most recent change of +$19.81 million (+157.34%) on December 31, 2023.
- During the last 3 years, TRVI annual cash & cash equivalents has fallen by -$12.60 million (-28.01%).
- TRVI annual cash & cash equivalents is now -43.47% below its all-time high of $57.31 million, reached on December 31, 2019.
Performance
TRVI Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$16.05 M
+$3.09 M+23.83%
September 30, 2024
Summary
- As of February 6, 2025, TRVI quarterly cash and cash equivalents is $16.05 million, with the most recent change of +$3.09 million (+23.83%) on September 30, 2024.
- Over the past year, TRVI quarterly cash and cash equivalents has dropped by -$16.34 million (-50.45%).
- TRVI quarterly cash and cash equivalents is now -77.51% below its all-time high of $71.39 million, reached on June 30, 2019.
Performance
TRVI Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TRVI Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +157.3% | -50.5% |
| 3 y3 years | -28.0% | -45.3% |
| 5 y5 years | +349.8% | -74.7% |
TRVI Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -12.0% | +157.3% | -75.9% | +37.8% |
| 5 y | 5-year | -43.5% | +157.3% | -75.9% | +37.8% |
| alltime | all time | -43.5% | +349.8% | -77.5% | +122.9% |
Trevi Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $16.05 M(+23.8%) |
| Jun 2024 | - | $12.96 M(-6.1%) |
| Mar 2024 | - | $13.81 M(-57.4%) |
| Dec 2023 | $32.40 M(+157.3%) | $32.40 M(+24.8%) |
| Sep 2023 | - | $25.96 M(+88.8%) |
| Jun 2023 | - | $13.75 M(+18.0%) |
| Mar 2023 | - | $11.65 M(-7.5%) |
| Dec 2022 | $12.59 M(-65.8%) | $12.59 M(-81.1%) |
| Sep 2022 | - | $66.57 M(+169.6%) |
| Jun 2022 | - | $24.70 M(-15.2%) |
| Mar 2022 | - | $29.11 M(-21.0%) |
| Dec 2021 | $36.83 M | $36.83 M(+25.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $29.32 M(-19.5%) |
| Jun 2021 | - | $36.42 M(-12.4%) |
| Mar 2021 | - | $41.57 M(-7.6%) |
| Dec 2020 | $45.00 M(-21.5%) | $45.00 M(-15.6%) |
| Sep 2020 | - | $53.29 M(+20.6%) |
| Jun 2020 | - | $44.18 M(-16.1%) |
| Mar 2020 | - | $52.64 M(-8.2%) |
| Dec 2019 | $57.31 M(+695.8%) | $57.31 M(-9.8%) |
| Sep 2019 | - | $63.52 M(-11.0%) |
| Jun 2019 | - | $71.39 M(+451.4%) |
| Mar 2019 | - | $12.95 M(+79.8%) |
| Dec 2018 | $7.20 M(-67.3%) | $7.20 M |
| Dec 2017 | $22.02 M | - |
FAQ
- What is Trevi Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Trevi Therapeutics?
- What is Trevi Therapeutics annual cash & cash equivalents year-on-year change?
- What is Trevi Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Trevi Therapeutics?
- What is Trevi Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Trevi Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of TRVI is $32.40 M
What is the all time high annual cash & cash equivalents for Trevi Therapeutics?
Trevi Therapeutics all-time high annual cash & cash equivalents is $57.31 M
What is Trevi Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, TRVI annual cash & cash equivalents has changed by +$19.81 M (+157.34%)
What is Trevi Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TRVI is $16.05 M
What is the all time high quarterly cash and cash equivalents for Trevi Therapeutics?
Trevi Therapeutics all-time high quarterly cash and cash equivalents is $71.39 M
What is Trevi Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, TRVI quarterly cash and cash equivalents has changed by -$16.34 M (-50.45%)